Name: Does a multiple myeloma patient whose disease has relapsed, need to undergo a 2nd ASCT?
Uploaded: 2018-12-13T10:19:43-0800
Duration: 2 min 43 s
Description: In this week’s video, Dr. Brian G.M. Durie discusses other options to consider if your doctor recommends a second autologous stem cell transplant. BOTTOM LINE: Discuss with your doctor the benefits and side effects of a second transplant as opposed to immune therapies and immune therapy combinations.

In this week’s video, Dr. Brian G.M. Durie discusses other options to consider if your doctor recommends a second autologous stem cell transplant.

BOTTOM LINE:
Discuss with your doctor the benefits and side effects of a second transplant as opposed to immune therapies and immune therapy combinations.

If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected].

To reach the IMF InfoLine Coordinators, please call 800.452.2873 or email them at [email protected].

Image of Dr. Brian G.M. Durie Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.